Niimi, Nozomi
Kohsaka, Shun http://orcid.org/0000-0003-3779-2972
Shiraishi, Yasuyuki
Takei, Makoto
Kohno, Takashi
Nakano, Shintaro
Nagatomo, Yuji
Sakamoto, Munehisa
Saji, Mike
Ikemura, Nobuhiro
Inohara, Taku
Ueda, Ikuko
Fukuda, Keiichi
Yoshikawa, Tsutomu
Funding for this research was provided by:
Grant-in-Aid for Young Scientists (18K15860)
Grant-in-Aid for Scientific Research (23591062, 26461088, 17K09526, 20H03915)
the Sakakibara Clinical Research Grant for Promotion of Sciences (2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020)
Grant from the Japan Agency for Medical Research and Development (201439013C)
Article History
Received: 14 February 2022
Accepted: 4 April 2023
First Online: 12 April 2023
Declarations
:
: S.K. received an unrestricted research grant for the Department of Cardiology, Keio University School of Medicine, from Novartis Pharma Co., Ltd and honoraria from Bayer, Bristol Myers Squibb and Pfizer. Y.S. is affiliated with an endowed department by Nippon Shinyaku Co., Ltd., Medtronic Japan Co., Ltd., and BIOTRONIK JAPAN Inc., and received research grants from the SECOM Science and Technology Foundation and the Uehara Memorial Foundation and honoraria from Otsuka Pharmaceuticals Co., Ltd., and Ono Pharmaceuticals Co., Ltd. N.I. received an unrestricted research grant for the Department of Cardiology, Keio University School of Medicine from Bristol Myer Squibb. Other authors have no conflicts of interest to disclose.